MADRAC Bulletin - 03/2019 Edition

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive



MADRAC Bulletin - 03/2019 Edition


Articles based on Case Report 

▪ Erythropoiesis-stimulating agents: A reminder on the cardiovascular risk in patients with chronic kidney disease

▪ Amiodarone: Risk of acute hepatitis

▪ Levothyroxine: Reminder on the risk of restlessness or irritability

▪ Immunisation anxiety-related reactions


What's New?

▪ List of Directives Related to Drug Safety Issues (September - December 2019)




National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400



Image   Image   Image   Image  


The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Thursday 20 June 2024, 10:17:13.
© Copyright 2023 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA


Main Menu English